We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
263 Secukinumab, a fully human anti-interleukin-17A monoclonal antibody, exhibits low immunogenicity in patients with psoriatic arthritis and ankylosing spondylitis during a 52week treatment period.
- Authors
McInnes, Iain B; Deodhar, Atul; Gladman, Dafna D; Ren, Mengyuan; Spindeldreher, Sebastian; Pricop, Luminita; Porter, Brian; Safi, Jorge; Shete, Abhijit; Bruin, Gerard
- Subjects
UNITED Kingdom; CONFERENCES &; conventions; ANKYLOSING spondylitis; MONOCLONAL antibodies; PSORIATIC arthritis
- Publication
Rheumatology, 2019, Vol 58, pN.PAG
- ISSN
1462-0324
- Publication type
Abstract
- DOI
10.1093/rheumatology/kez107.079